Company Profile
Changde Yungang Biotechnology Co., Ltd.
The company is an export-oriented high-tech enterprise, mainly engaged in animal bile source technology research and development and application.
The main products are bile acid series and various animal bile active extracts. Around the industrial positioning, Yungang has successively developed a series of products such as chenodeoxycholic acid, ursodeoxycholic acid, bilirubin, bile salt, bile acid feeding, etc., and has been applied to drugs, microbial detection reagents, animal health care, etc. Among them, the main product "ursodeoxycholic acid intermediate" market share, ranking first in the industry.
production base
Products are exported to many countries and regions
The company was established in
Product Introduction
Insist on independent research and development and technological innovation
Calcium bilirubinate is the primary raw material for the production of in vitro–cultured bezoar, meeting the standards set forth in the Chinese Pharmacopoeia; custom formulations can be provided based on customer-specified quality specifications.
Biochemical research; culture medium raw materials; also used for anti-inflammatory purposes;
7-ketolithocholic acid (7K-LCA)
Intermediate raw materials for the production of lithocholic acid, obeticholic acid, and deoxycholic acid.
It's the main raw material for making artificial bezoar. With sedation; anticonvulsive; antipyretic; antihypertensive. Promote the role of red blood cell regeneration.
Patent Certificate
Insist on independent research and development and technological innovation
Blog
More than 20 years of industry precipitation
Industry Information
2026/04/28
The 94th China International API, Intermediates, Packaging and Equipment Exhibition (API China) will be held at the Shanghai National Exhibition and Convention Center, in conjunction with the 92nd National Pharmaceutical Trade Fair and the 2026 China International Health & Nutrition Expo, all taking place at the same venue and during the same period.
2026/04/09
The 2026 China Feed Industry Exhibition will be held from April 18 to 20 at the Nanchang Greenland International Expo Center. Yungang Bio— a national high-tech enterprise specializing in bile acids—cordially invites you to visit Booth B3E193. The company will showcase three key strengths: more than 20 patented inventions in the fields of biopharmaceuticals and animal health, underscoring its patent leadership; a 1,500-square-meter R&D center supported by a team of nearly 60 experts, ensuring robust R&D capabilities; and active participation in the development of national standards coupled with a 10,000-ton-scale smart production line, guaranteeing reliable supply. With a steadfast focus on innovation in bile acids, we look forward to “making waves” together in Nanchang and exploring collaborative opportunities for the future!
2026/04/08
From November 12 to 14, 2025, Changde Yungang Bio will make its debut at the API China Chongqing exhibition, showcasing a comprehensive portfolio of bile-related products, including bilirubin, chenodeoxycholic acid, ursodeoxycholic acid, bile salts, and bile acid feed additives. During the event, the company engaged in in-depth exchanges with industry peers on technological trends and market demands, expanded its network of collaborative partners, and received an enthusiastic response from attendees. Looking ahead, Yungang Bio will continue to deepen its expertise in the bile resource sector, delivering higher-quality products and services to customers and working together to create new value for the industry.
2025/05/30
Highlights from Yungang Bio’s 2025 API China Guangzhou Expo
The 92nd API China exhibition was successfully held in Guangzhou. YunGang Bio showcased a comprehensive portfolio of products, including chenodeoxycholic acid, ursodeoxycholic acid, bilirubin, bile salts, and bile acids, attracting numerous new and existing customers and partners who stopped by to discuss potential collaborations. Through in-depth exchanges with on-site clients, the company gained a clearer understanding of market demands and industry trends. Moving forward, YunGang Bio will remain committed to delivering high-quality products and services and working hand-in-hand with industry partners to drive continued progress.
2024/11/18
Changde Yungang debuts at the 2024 CPHI Europe Exhibition.
From October 8 to 10, the three-day global top pharmaceutical event
Company address: No.8 fenglin road, Sujiadu Community, Zhangmuqiao Street, Changde Economic and Technological Development Zone, Hunan Province